X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
humans (10) 10
chemotherapy (9) 9
clinical trials (8) 8
female (8) 8
lymphomas (8) 8
male (8) 8
cancer (6) 6
hematology (6) 6
lymphoma (6) 6
abridged index medicus (5) 5
adult (5) 5
aged (5) 5
aged, 80 and over (5) 5
cyclophosphamide (5) 5
hematology, oncology and palliative medicine (5) 5
middle aged (5) 5
non-hodgkins-lymphoma (5) 5
oncology (5) 5
rituximab (5) 5
survival (5) 5
vincristine (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
internal medicine (4) 4
medicine, general & internal (4) 4
patients (4) 4
prednisone (4) 4
response criteria (4) 4
therapy (4) 4
treatment outcome (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
cyclophosphamide - administration & dosage (3) 3
disease-free survival (3) 3
doxorubicin (3) 3
doxorubicin - administration & dosage (3) 3
drug administration schedule (3) 3
indolent (3) 3
kaplan-meier estimate (3) 3
lymphoma, large b-cell, diffuse - drug therapy (3) 3
multicenter (3) 3
neutropenia (3) 3
prednisone - administration & dosage (3) 3
prognosis (3) 3
side effects (3) 3
studies (3) 3
transplantation (3) 3
vincristine - administration & dosage (3) 3
[sdv.can] life sciences [q-bio]/cancer (2) 2
aged patients (2) 2
aggressive lymphomas (2) 2
anthracyclines (2) 2
antibodies, monoclonal, murine-derived - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
b-cell lymphoma (2) 2
cancer therapies (2) 2
cell survival (2) 2
consensus (2) 2
corticosteroids (2) 2
cyclophosphamide - adverse effects (2) 2
cyclophosphamide - therapeutic use (2) 2
cytarabine - administration & dosage (2) 2
disease progression (2) 2
doxorubicin - adverse effects (2) 2
doxorubicin - therapeutic use (2) 2
drug therapy (2) 2
elderly-patients (2) 2
epidemiology (2) 2
europe (2) 2
free survival (2) 2
immunologic factors - therapeutic use (2) 2
intention to treat analysis (2) 2
lenalidomide (2) 2
life sciences (2) 2
lymphoma - diagnostic imaging (2) 2
lymphoma, large b-cell, diffuse - mortality (2) 2
lymphoma, mantle-cell - therapy (2) 2
medical prognosis (2) 2
medical research (2) 2
motivation (2) 2
non-hodgkins-lymphomas (2) 2
pet (2) 2
plus rituximab (2) 2
positron-emission tomography - methods (2) 2
prednisone - adverse effects (2) 2
prednisone - therapeutic use (2) 2
product development (2) 2
prospective studies (2) 2
randomization (2) 2
response assessment (2) 2
risk factors (2) 2
time factors (2) 2
toxicity (2) 2
tumors (2) 2
vincristine - adverse effects (2) 2
vincristine - therapeutic use (2) 2
1st-line treatment (1) 1
[ sdv ] life sciences [q-bio] (1) 1
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
[sdv]life sciences [q-bio] (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 42 - 51
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9806, pp. 1858 - 1867
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 460 - 468
Summary Background Diffuse large B-cell lymphoma is a common cancer in elderly patients. Although treatment has been standardised in younger patients, no... 
Hematology, Oncology and Palliative Medicine | MAINTENANCE RITUXIMAB | COLONY-STIMULATING FACTOR | PROGNOSTIC-FACTORS | RESPONSE CRITERIA | ONCOLOGY | AGGRESSIVE LYMPHOMAS | MALIGNANT-LYMPHOMAS | NON-HODGKINS-LYMPHOMA | COMPREHENSIVE GERIATRIC ASSESSMENT | DETUDE-DES-LYMPHOMES | CHOP CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Aged, 80 and over | Vincristine - administration & dosage | Female | France | Odds Ratio | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Risk Factors | Rituximab | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Analysis of Variance | Belgium | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - adverse effects | Doxorubicin - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Anthracyclines | Cyclophosphamide | Chemotherapy | Corticosteroids | Oncology, Experimental | Aged patients | Product development | Prednisone | Lymphomas | Research | Cancer | Toxicity | Albumin | Clinical trials | Multivariate analysis | Doxorubicin | Survival | Vincristine | Side effects | Motivation | Age | rituximab | B-cell lymphoma | Geriatrics | Neutropenia
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 525 - 533
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2017, Volume 4, Issue 1, pp. e46 - e55
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 510 - 519
Summary Background Listeriosis is a severe foodborne infection and a notifiable disease in France. We did a nationwide prospective study to characterise its... 
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Life Sciences
Journal Article